Loading…

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised $5 Billion in a Series C funding round.
To respect copyright, we link to the source rather than republishing the full text. Read the complete article on TechCrunch.